# Ernexa Therapeutics Inc.: Form 8-K, filed Jan 19, 2024

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2024-01-19
- Accepted by EDGAR: Jan 19, 2024, 16:16 ET
- Period: 2024-01-17
- Accession: 0001140361-24-002915
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036124002915/ef20019104_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036124002915/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036124002915/ef20019104_8k.htm

Filed Jan 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-002915. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.